Mandlekar S, Hebbar V, Christov K, Kong AN: Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines. Cancer Res. 2000, 60: 6601-6606.
CAS
PubMed
Google Scholar
Jordan VC: Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol. 1993, 110: 507-517.
Article
CAS
PubMed Central
PubMed
Google Scholar
Wijayaratne AL, Nagel SC, Paige LA, Christensen DJ, Norris JD, Fowlkes DM, McDonnell DP: Comparative analyses of mechanistic differences among antiestrogens. Endocrinology. 1999, 140: 5828-5840.
CAS
PubMed
Google Scholar
Johnson MD, Zuo H, Lee KH, Trebley JP, Rae JM, Weatherman RV, Desta Z, Flockhart DA, Skaar TC: Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen. Breast Cancer Res Treat. 2004, 85: 151-159.
Article
CAS
PubMed
Google Scholar
Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell. 1994, 78: 539-542.
Article
CAS
PubMed
Google Scholar
Carthew P, Edwards RE, Nolan BM, Tucker MJ, Smith LL: Compartmentalized uterotrophic effects of tamoxifen, toremifene, and estradiol in the ovariectomized Wistar (Han) rat. Toxicol Sci. 1999, 48: 197-205.
Article
CAS
PubMed
Google Scholar
Kohlerova E, Skarda J: Mouse bioassay to assess oestrogenic and anti-oestrogenic compounds: hydroxytamoxifen, diethylstilbestrol and genistein. J Vet Med A Physiol Pathol Clin Med. 2004, 51: 209-217.
Article
CAS
PubMed
Google Scholar
Osborne CK, Zhao H, Fuqua SA: Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol. 2000, 18: 3172-3186.
CAS
PubMed
Google Scholar
Lewis JS, Jordan VC: Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance. Mutat Res. 2005, 591: 247-263.
Article
CAS
PubMed
Google Scholar
Smith CL, Nawaz Z, O'Malley BW: Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol. 1997, 11: 657-666.
Article
CAS
PubMed
Google Scholar
Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N: Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. Jama. 2006, 295: 2727-2741.
Article
CAS
PubMed
Google Scholar
Reel JR, Lamb IJ, Neal BH: Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam Appl Toxicol. 1996, 34: 288-305.
Article
CAS
PubMed
Google Scholar
Jordan VC, Collins MM, Rowsby L, Prestwich G: A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J Endocrinol. 1977, 75: 305-316.
Article
CAS
PubMed
Google Scholar
Boverhof DR, Fertuck KC, Burgoon LD, Eckel JE, Gennings C, Zacharewski TR: Temporal- and dose-dependent hepatic gene expression changes in immature ovariectomized mice following exposure to ethynyl estradiol. Carcinogenesis. 2004, 25: 1277-1291.
Article
CAS
PubMed
Google Scholar
Fertuck KC, Eckel JE, Gennings C, Zacharewski TR: Identification of temporal patterns of gene expression in the uteri of immature, ovariectomized mice following exposure to ethynylestradiol. Physiol Genomics. 2003, 15: 127-141.
Article
CAS
PubMed
Google Scholar
Kwekel JC, Burgoon LD, Burt JW, Harkema JR, Zacharewski TR: A cross-species analysis of the rodent uterotrophic program: elucidation of conserved responses and targets of estrogen signaling. Physiol Genomics. 2005, 23: 327-342.
Article
CAS
PubMed
Google Scholar
Van den Belt K, Berckmans P, Vangenechten C, Verheyen R, Witters H: Comparative study on the in vitro/in vivo estrogenic potencies of 17beta-estradiol, estrone, 17alpha-ethynylestradiol and nonylphenol. Aquat Toxicol. 2004, 66: 183-195.
Article
CAS
PubMed
Google Scholar
Carthew P, Edwards RE, Nolan BM: Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse. Toxicol Appl Pharmacol. 1999, 158: 24-32.
Article
CAS
PubMed
Google Scholar
Jordan VC, Dix CJ, Naylor KE, Prestwich G, Rowsby L: Nonsteroidal antiestrogens: their biological effects and potential mechanisms of action. J Toxicol Environ Health. 1978, 4: 363-390.
Article
CAS
PubMed
Google Scholar
Jordan VC, Dix CJ: Effect of oestradiol benzoate, tamoxifen and monohydroxytamoxifen on immature rat uterine progesterone receptor synthesis and endometrial cell division. J Steroid Biochem. 1979, 11: 285-291.
Article
CAS
PubMed
Google Scholar
Loeb L, Suntzeff V, Burns EL: Growth processes induced by estrogenic hormones in the uterus of the mouse. Am J Cancer. 1938, 34: 413-427.
CAS
PubMed
Google Scholar
Moggs JG, Tinwell H, Spurway T, Chang HS, Pate I, Lim FL, Moore DJ, Soames A, Stuckey R, Currie R, Zhu T, Kimber I, Ashby J, Orphanides G: Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ Health Perspect. 2004, 112: 1589-1606.
Article
CAS
PubMed Central
PubMed
Google Scholar
Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC: Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 2002, 30: e48-
Article
PubMed Central
PubMed
Google Scholar
Bourdeau V, Deschenes J, Metivier R, Nagai Y, Nguyen D, Bretschneider N, Gannon F, White JH, Mader S: Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol Endocrinol. 2004, 18: 1411-1427.
Article
CAS
PubMed
Google Scholar
Black LJ, Goode RL: Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice. Life Sci. 1980, 26: 1453-1458.
Article
CAS
PubMed
Google Scholar
Fromson JM, Pearson S, Bramah S: The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals. Xenobiotica. 1973, 3: 693-709.
Article
CAS
PubMed
Google Scholar
Fromson JM, Pearson S, Bramah S: The metabolism of tamoxifen (I.C.I. 46,474). II. In female patients. Xenobiotica. 1973, 3: 711-714.
Article
CAS
PubMed
Google Scholar
Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC: Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos. 1991, 19: 36-43.
CAS
PubMed
Google Scholar
Kiriwat O, Fotherby K: Pharmacokinetics of oral contraceptive steroids after morning or evening administration. Contraception. 1983, 27: 153-160.
Article
CAS
PubMed
Google Scholar
Gray CA, Bartol FF, Tarleton BJ, Wiley AA, Johnson GA, Bazer FW, Spencer TE: Developmental biology of uterine glands. Biol Reprod. 2001, 65: 1311-1323.
Article
CAS
PubMed
Google Scholar
Sanyal A, Riggs BL, Spelsberg TC, Khosla S: Bone marrow stromal cells express two distinct splice variants of ER-alpha that are regulated by estrogen. J Cell Biochem. 2005, 94: 88-97.
Article
CAS
PubMed
Google Scholar
Boverhof DR, Burgoon LD, Tashiro C, Chittim B, Harkema JR, Jump DB, Zacharewski TR: Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity. Toxicol Sci. 2005, 85: 1048-1063.
Article
CAS
PubMed
Google Scholar
Naciff JM, Overmann GJ, Torontali SM, Carr GJ, Tiesman JP, Richardson BD, Daston GP: Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol Sci. 2003, 72: 314-330.
Article
CAS
PubMed
Google Scholar
Yamashita S, Takayanagi A, Shimizu N: Temporal and cell-type specific expression of c-fos and c-jun protooncogenes in the mouse uterus after estrogen stimulation. Endocrinology. 1996, 137: 5468-5475.
CAS
PubMed
Google Scholar
Fan TJ, Han LH, Cong RS, Liang J: Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai). 2005, 37: 719-727.
Article
CAS
Google Scholar
Lai MD, Jiang MJ, Wing LY: Estrogen stimulates expression of p21Waf1/Cip1 in mouse uterine luminal epithelium. Endocrine. 2002, 17: 233-239.
Article
CAS
PubMed
Google Scholar
Kirkland JL, Murthy L, Stancel GM: Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus. Mol Pharmacol. 1993, 43: 709-714.
CAS
PubMed
Google Scholar
Mylonas I, Jeschke U, Wiest I, Hoeing A, Vogl J, Shabani N, Kuhn C, Schulze S, Kupka MS, Friese K: Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle. Histochem Cell Biol. 2004, 122: 461-471.
Article
CAS
PubMed
Google Scholar
Nakayama H, Sano T, Motegi A, Oyama T, Nakajima T: Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma. Pathol Int. 2005, 55: 707-715.
Article
CAS
PubMed
Google Scholar
Krebs J, Saremaslani P, Caduff R: ALG-2: a Ca2+ -binding modulator protein involved in cell proliferation and in cell death. Biochim Biophys Acta. 2002, 1600: 68-73.
Article
CAS
PubMed
Google Scholar
Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, Fonseca R, Smyrk TC, Chari ST, Urrutia R, Billadeau DD: Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell. 2005, 7: 39-49.
Article
CAS
PubMed
Google Scholar
Mehus JG, Deloukas P, Lambeth DO: NME6: a new member of the nm23/nucleoside diphosphate kinase gene family located on human chromosome 3p21.3. Hum Genet. 1999, 104: 454-459.
Article
CAS
PubMed
Google Scholar
Rampazzo C, Kost-Alimova M, Ruzzenente B, Dumanski JP, Bianchi V: Mouse cytosolic and mitochondrial deoxyribonucleotidases: cDNA cloning of the mitochondrial enzyme, gene structures, chromosomal mapping and comparison with the human orthologs. Gene. 2002, 294: 109-117.
Article
CAS
PubMed
Google Scholar
Jablonski EM, McConnell NA, Hughes FM, Huet-Hudson YM: Estrogen regulation of aquaporins in the mouse uterus: potential roles in uterine water movement. Biol Reprod. 2003, 69: 1481-1487.
Article
CAS
PubMed
Google Scholar
Koyama N, Ishibashi K, Kuwahara M, Inase N, Ichioka M, Sasaki S, Marumo F: Cloning and functional expression of human aquaporin8 cDNA and analysis of its gene. Genomics. 1998, 54: 169-172.
Article
CAS
PubMed
Google Scholar
McMahon RJ, Cousins RJ: Mammalian zinc transporters. J Nutr. 1998, 128: 667-670.
CAS
PubMed
Google Scholar
Suzuki T, Ishihara K, Migaki H, Matsuura W, Kohda A, Okumura K, Nagao M, Yamaguchi-Iwai Y, Kambe T: Zinc transporters, ZnT5 and ZnT7, are required for the activation of alkaline phosphatases, zinc-requiring enzymes that are glycosylphosphatidylinositol-anchored to the cytoplasmic membrane. J Biol Chem. 2005, 280: 637-643.
Article
CAS
PubMed
Google Scholar
Lee JY, Kim JH, Hong SH, Cherny RA, Bush AI, Palmiter RD, Koh JY: Estrogen decreases zinc transporter 3 expression and synaptic vesicle zinc levels in mouse brain. J Biol Chem. 2004, 279: 8602-8607.
Article
CAS
PubMed
Google Scholar
Burckhardt BC, Burckhardt G: Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol. 2003, 146: 95-158.
Article
CAS
PubMed
Google Scholar
Ljubojevic M, Balen D, Breljak D, Kusan M, Anzai N, Bahn A, Burckhardt G, Sabolic I: Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. Am J Physiol Renal Physiol. 2006
Google Scholar
Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, Hayashi S: Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol. 2002, 29: 175-192.
Article
CAS
PubMed
Google Scholar
del Carmen Garcia Molina Wolgien M, da Silva ID, Villanova FE, Yumi Otsuka A, Borra RC, Lima Reis LF, Carvalho AF, Baracat EC, Gebrim LH: Differential gene expression assessed by cDNA microarray analysis in breast cancer tissue under tamoxifen treatment. Eur J Gynaecol Oncol. 2005, 26: 501-504.
CAS
PubMed
Google Scholar
Scafoglio C, Ambrosino C, Cicatiello L, Altucci L, Ardovino M, Bontempo P, Medici N, Molinari AM, Nebbioso A, Facchiano A, Calogero RA, Elkon R, Menini N, Ponzone R, Biglia N, Sismondi P, Bortoli MD, Weisz A: Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006
Google Scholar
Gadal F, Starzec A, Bozic C, Pillot-Brochet C, Malinge S, Ozanne V, Vicenzi J, Buffat L, Perret G, Iris F, Crepin M: Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells. J Mol Endocrinol. 2005, 34: 61-75.
Article
CAS
PubMed
Google Scholar
Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS: Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res. 2004, 64: 1522-1533.
Article
CAS
PubMed
Google Scholar
Frasor J, Chang EC, Komm B, Lin CY, Vega VB, Liu ET, Miller LD, Smeds J, Bergh J, Katzenellenbogen BS: Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res. 2006, 66: 7334-7340.
Article
CAS
PubMed
Google Scholar
Hodges LC, Cook JD, Lobenhofer EK, Li L, Bennett L, Bushel PR, Aldaz CM, Afshari CA, Walker CL: Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. Mol Cancer Res. 2003, 1: 300-311.
CAS
PubMed
Google Scholar
Green AR, Styles JA, Parrott EL, Gray D, Edwards RE, Smith AG, Gant TW, Greaves P, Al-Azzawi F, White IN: Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer. Exp Toxicol Pathol. 2005, 56: 255-263.
Article
CAS
PubMed
Google Scholar
Robertson DW, Katzenellenbogen JA, Hayes JR, Katzenellenbogen BS: Antiestrogen basicity--activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity. J Med Chem. 1982, 25: 167-171.
Article
CAS
PubMed
Google Scholar
Dowsett M, Haynes BP: Hormonal effects of aromatase inhibitors: focus on premenopausal effects and interaction with tamoxifen. J Steroid Biochem Mol Biol. 2003, 86: 255-263.
Article
CAS
PubMed
Google Scholar
Giambiagi N, Pasqualini JR: Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies. J Steroid Biochem. 1988, 30: 213-217.
Article
CAS
PubMed
Google Scholar
Webb P, Nguyen P, Kushner PJ: Differential SERM effects on corepressor binding dictate ERalpha activity in vivo. J Biol Chem. 2003, 278: 6912-6920.
Article
CAS
PubMed
Google Scholar
McDonnell DP, Chang CY, Norris JD: Development of peptide antagonists that target estrogen receptor-cofactor interactions. J Steroid Biochem Mol Biol. 2000, 74: 327-335.
Article
CAS
PubMed
Google Scholar
Geum D, Sun W, Paik SK, Lee CC, Kim K: Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3. Mol Reprod Dev. 1997, 46: 450-458.
Article
CAS
PubMed
Google Scholar
Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL: The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 1998, 95: 927-937.
Article
CAS
PubMed
Google Scholar
Das D, Peterson RC, Scovell WM: High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity. Mol Endocrinol. 2004, 18: 2616-2632.
Article
CAS
PubMed
Google Scholar
Kazmin D, Prytkova T, Cook CE, Wolfinger R, Chu TM, Beratan D, Norris JD, Chang CY, McDonnell DP: Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators. Mol Endocrinol. 2006, 20: 1201-1217.
Article
CAS
PubMed
Google Scholar
Meijer OC, Kalkhoven E, van der Laan S, Steenbergen PJ, Houtman SH, Dijkmans TF, Pearce D, de Kloet ER: Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology. 2005, 146: 1438-1448.
Article
CAS
PubMed
Google Scholar
Lim CK, Yuan ZX, Lamb JH, White IN, De Matteis F, Smith LL: A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. Carcinogenesis. 1994, 15: 589-593.
Article
CAS
PubMed
Google Scholar
White IN: Tamoxifen: is it safe? Comparison of activation and detoxication mechanisms in rodents and in humans. Curr Drug Metab. 2003, 4: 223-239.
Article
CAS
PubMed
Google Scholar
Goetz MP, Knox SK, Suman VJ, Rae JM, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Weinshilboum RM, Fritcher EG, Nibbe AM, Desta Z, Nguyen A, Flockhart DA, Perez EA, Ingle JN: The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat. 2007, 101: 113-121.
Article
CAS
PubMed
Google Scholar
Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bouedec G, Penault-Llorca F: Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol. 2000, 78: 181-186.
Article
CAS
PubMed
Google Scholar
Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG: Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol. 2001, 97: 855-866.
Article
CAS
PubMed
Google Scholar
Human Pathology @ Michigan State University. [http://www.humanpathology.msu.edu/histology]
Research Technology Support Facility. [http://www.genomics.msu.edu]
Rockett JC, Dix DJ: Application of DNA arrays to toxicology. Environ Health Perspect. 1999, 107: 681-685.
Article
CAS
PubMed Central
PubMed
Google Scholar
dbZACH Home Page: Zacharewski Laboratory. [http://dbzach.fst.msu.edu/]
Burgoon LD, Eckel-Passow JE, Gennings C, Boverhof DR, Burt JW, Fong CJ, Zacharewski T: Protocols for the Assurance of Microarray Data Quality and Process Control. Nucleic Acids Research. 2005, 33: e172-
Article
CAS
PubMed Central
PubMed
Google Scholar
Eckel JE, Gennings C, Therneau TM, Burgoon LD, Boverhof DR, Zacharewski TR: Normalization of two-channel microarray experiments: a semiparametric approach. Bioinformatics. 2005, 21: 1078-1083.
Article
CAS
PubMed
Google Scholar
Eckel JE, Gennings C, Chinchilli VM, Burgoon LD, Zacharewski TR: Empirical bayes gene screening tool for time-course or dose-response microarray data. J Biopharm Stat. 2004, 14: 647-670.
Article
CAS
PubMed
Google Scholar
Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001, 29: 365-371.
Article
CAS
PubMed
Google Scholar
Burgoon LD, Boutros PC, Dere E, Zacharewski TR: dbZach: A MIAME-Compliant Toxicogenomic Supportive Relational Database. Toxicol Sci. 2005
Google Scholar
Primer3 Input (primer3/input.htm version 0.3.0 modified for WI). [http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi]